Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence

Although clinical trials and real-world studies have affirmed the effectiveness and safety of the FDA-authorized COVID-19 vaccines, reports of breakthrough infections and persistent emergence of new variants highlight the need to vigilantly monitor the effectiveness of these vaccines. Here we compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Puranik, Arjun, Lenehan, Patrick J., Silvert, Eli, Niesen, Michiel J.M., Corchado-Garcia, Juan, O’Horo, John C., Virk, Abinash, Swift, Melanie D., Halamka, John, Badley, Andrew D., Venkatakrishnan, A.J., Soundararajan, Venky
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366801/
https://www.ncbi.nlm.nih.gov/pubmed/34401884
http://dx.doi.org/10.1101/2021.08.06.21261707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8366801/
https://www.ncbi.nlm.nih.gov/pubmed/34401884
http://dx.doi.org/10.1101/2021.08.06.21261707

Ejemplares similares